Siste måned

30 dager
+1 301 168
NETTO POSISJON (NOK)
Handler
6
Kjøp
1 301 168
Salg
0

6 måneder

180 dager
+1 870 119
NETTO POSISJON (NOK)
Handler
36
Kjøp
1 903 742
Salg
33 623

Historikk

ℹ️ Om innsidehandel

Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.

Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.

Transaksjoner

Dato Innsider Antall Pris Verdi
03.06.2026
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
31 500 8.25 259 900
03.06.2026
Thomas Birkballe Hansen
Chief Technology Officer
24 241 8.25 200 008
01.06.2026
Victor Levitsky
Chief Scientific Officer
30 300 8.25 249 999
29.05.2026
Ola Melin
Chief Operation Officer
24 241 8.25 200 008
28.05.2026
Erik Digman Wiklund
CEO
via Digman AS
42 420 8.25 349 999
27.05.2026
Robert Forbes Burns
Deputy Board member
5 000 8.25 41 254
06.05.2026
Damian Marron
Chairman
14 012 0.60 8 407
06.05.2026
Thomas Falck
Board member
4 041 8.32 33 623
06.05.2026
Thomas Falck
Board member
10 376 0.60 6 226
06.05.2026
Diane Mary Mellet
Board member
2 020 0.60 1 212
30.01.2026
Damian Marron
Chairman
128 595 1.00 128 595
13.02.2026
Victor Levitsky
Chief Scientific Officer
500 000 - -
13.02.2026
Ola Melin
Chief Operation Officer
500 000 - -
13.02.2026
Thomas Birkballe Hansen
Chief Technology Officer
750 000 - -
13.02.2026
Lubor Gaal
CFO
750 000 - -
13.02.2026
Erik Digman Wiklund
CEO
1 200 000 - -
28.01.2026
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
65 164 1.00 65 164
27.01.2026
Thomas Falck
Board member
via Sølen AS
65 164 1.00 65 164
26.01.2026
Victor Levitsky
Chief Scientific Officer
32 698 1.00 32 698
21.01.2026
Robert Forbes Burns
Deputy Board member
11 542 1.00 11 542
21.01.2026
Diane Mary Mellet
Board member
60 000 1.00 60 000
21.01.2026
Damian Marron
Chairman
58 918 1.00 58 918
21.01.2026
Ola Melin
Chief Operation Officer
33 161 1.00 33 161
19.01.2026
Thomas Birkballe Hansen
Chief Technology Officer
32 582 1.00 32 582
16.01.2026
Erik Digman Wiklund
CEO
via Digman AS
1 160 1.00 1 160
16.01.2026
Erik Digman Wiklund
CEO
97 746 1.00 97 746
15.01.2026
Ola Melin
Chief Operation Officer
33 162 - -
15.01.2026
Erik Digman Wiklund
CEO
97 746 - -
15.01.2026
Erik Digman Wiklund
CEO
via Digman AS
1 160 - -
15.01.2026
Damian Marron
Chairman
58 918 - -
15.01.2026
Robert Forbes Burns
Deputy Board member
30 792 - -
15.01.2026
Diane Mary Mellet
Board member
67 405 - -
15.01.2026
Thomas Falck
Board member
via Sølen AS
65 164 - -
15.01.2026
Victor Levitsky
Chief Scientific Officer
32 698 - -
15.01.2026
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
65 164 - -
15.01.2026
Thomas Birkballe Hansen
Chief Technology Officer
32 582 - -
Vis alle 36 transaksjoner

Pressemeldinger

Dato Melding
04.06.2026
Circio Holding ASA Exercise of Warrants by primary insiders
Oslo, 4 June 2026: Reference is made to the stock exchange announcement published by Circio Holding ASA (the "Company") on 26 May 2026 regarding comme...
02.06.2026
Circio Holding ASA Exercise of Warrants by primary insiders
Oslo, 2 June 2026: Reference is made to the stock exchange announcement published by Circio Holding ASA (the "Company") on 26 May 2026 regarding comme...
29.05.2026
Circio Holding ASA Exercise of Warrants by primary insiders
Oslo, 29 May 2026: Reference is made to the stock exchange announcement published by Circio Holding ASA (the "Company") on 26 May 2026 regarding comme...
07.05.2026
Circio Holding ASA: Mandatory notification of trade by primary insiders pertaining to settlement of RSUs
Oslo, 7 May 2026: Reference is made to Circio Holding ASA's (OSE: CRNA) (the "Company") stock exchange announcement published on 6 May 2026, regarding...
26.02.2026
Correction - Mandatory notification of trade by primary insider related to the rights issue
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, ...
14.02.2026
Circio announces allocation of stock options to key employees
Oslo, Norway, 14 February 2026 -- Circio Holding ASA (OSE: CRNA), a biotechnology company developing novel circular RNA expression technology for gene...
29.01.2026
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 29 January 2026: Reference is made to the stock exchange announcements by Circio Holding ASA (the "Company") on 15 January 2026, regarding the c...
28.01.2026
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 28 January 2026: Reference is made to the stock exchange announcements by Circio Holding ASA (the "Company") on 15 January 2026, regarding the c...
21.01.2026
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 21 January 2026: Reference is made to the stock exchange announcements by Circio Holding ASA (the "Company") on 15 January 2026, regarding the c...
16.01.2026
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 16 January 2026: Reference is made to the stock exchange announcements by Circio Holding ASA (the "Company") on 15 January 2026, regarding the c...
15.01.2026
Circio Holding ASA Receipt of subscription rights in the rights issue by primary insiders and their close associates
Oslo, 15 January 2026: Reference is made to the stock exchange announcement by Circio Holding ASA (the "Company") earlier today, 15 January 2026, rega...
Vis alle 11 meldinger